insulin icodec

💊Medication

Generic name

Insulin Icodec-Abae

Brand names

Awiqli

Route

Subcutaneous

Type

Human Prescription Drug

Manufacturer

Novo Nordisk

Indications: 1 INDICATIONS AND USAGE Awiqli is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Awiqli is a long-acting human insulin analog indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes… (per FDA label)

• PHASE3COMPLETED
  A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin BeforeNovo Nordisk A/S · NCT04760626
• PHASE1COMPLETED
  A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Insulin Icodec in Subjects With Type 2 DiabetesNovo Nordisk A/S · NCT04582435
• PHASE3COMPLETED
  A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9)Novo Nordisk A/S · NCT05823948
• PHASE1COMPLETED
  A Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged FastingNovo Nordisk A/S · NCT06288412
• PHASE3COMPLETED
  A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6)Novo Nordisk A/S · NCT04848480
• PHASE3COMPLETED
  A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin IcodecNovo Nordisk A/S · NCT05352815

via ClinicalTrials.gov